These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 38117792)
1. Prospective healthcare-associated links in transmission of nontuberculous mycobacteria among people with cystic fibrosis (pHALT NTM) study: Rationale and study design. Gross JE; Caceres S; Poch K; Epperson LE; Hasan NA; Jia F; Calado Nogueira de Moura V; Strand M; Lipner EM; Honda JR; Strong M; Davidson RM; Daley CL; Nick JA PLoS One; 2023; 18(12):e0291910. PubMed ID: 38117792 [TBL] [Abstract][Full Text] [Related]
2. Healthcare-associated links in transmission of nontuberculous mycobacteria among people with cystic fibrosis (HALT NTM) study: Rationale and study design. Gross JE; Caceres S; Poch K; Hasan NA; Davidson RM; Epperson LE; Lipner E; Vang C; Honda JR; Strand M; Strong M; Saiman L; Prevots DR; Olivier KN; Nick JA PLoS One; 2021; 16(12):e0261628. PubMed ID: 34929010 [TBL] [Abstract][Full Text] [Related]
3. Molecular Epidemiologic Investigation of Gross JE; Teneback CC; Sweet JG; Caceres SM; Poch KR; Hasan NA; Jia F; Epperson LE; Lipner EM; Vang CK; Honda JR; Strand MJ; Calado Nogueira de Moura V; Daley CL; Strong M; Davidson RM; Nick JA Ann Am Thorac Soc; 2023 May; 20(5):677-686. PubMed ID: 36656594 [No Abstract] [Full Text] [Related]
4. Investigating Nontuberculous Mycobacteria Transmission at the Colorado Adult Cystic Fibrosis Program. Gross JE; Caceres S; Poch K; Hasan NA; Jia F; Epperson LE; Lipner E; Vang C; Honda JR; Strand M; Calado Nogueira de Moura V; Daley CL; Strong M; Davidson RM; Nick JA Am J Respir Crit Care Med; 2022 May; 205(9):1064-1074. PubMed ID: 35085056 [No Abstract] [Full Text] [Related]
5. Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT study. Martiniano SL; Caceres SM; Poch K; Rysavy NM; Lovell VK; Armantrout E; Jones M; Anthony M; Keck A; Nichols DP; Vandalfsen JM; Sagel SD; Wagner B; Xie J; Weaver K; Heltshe SL; Daley CL; Davidson RM; Nick JA; J Cyst Fibros; 2024 Jan; 23(1):50-57. PubMed ID: 37666709 [TBL] [Abstract][Full Text] [Related]
6. Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010-2019). Marshall JE; Mercaldo RA; Lipner EM; Prevots DR BMC Infect Dis; 2023 Jul; 23(1):489. PubMed ID: 37488500 [TBL] [Abstract][Full Text] [Related]
7. Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators. Burke A; Thomson RM; Wainwright CE; Bell SC Semin Respir Crit Care Med; 2023 Apr; 44(2):287-296. PubMed ID: 36649736 [TBL] [Abstract][Full Text] [Related]
12. Phylogenomics of nontuberculous mycobacteria respiratory infections in people with cystic fibrosis. Bolden N; Mell JC; Logan JB; Planet PJ Paediatr Respir Rev; 2023 Jun; 46():63-70. PubMed ID: 36828670 [TBL] [Abstract][Full Text] [Related]
13. Whole genome sequencing of Nontuberculous Mycobacterium (NTM) isolates from sputum specimens of co-habiting patients with NTM pulmonary disease and NTM isolates from their environment. Yoon JK; Kim TS; Kim JI; Yim JJ BMC Genomics; 2020 Apr; 21(1):322. PubMed ID: 32326890 [TBL] [Abstract][Full Text] [Related]
14. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Bryant JM; Grogono DM; Greaves D; Foweraker J; Roddick I; Inns T; Reacher M; Haworth CS; Curran MD; Harris SR; Peacock SJ; Parkhill J; Floto RA Lancet; 2013 May; 381(9877):1551-60. PubMed ID: 23541540 [TBL] [Abstract][Full Text] [Related]
15. Nontuberculous mycobacterial infection and environmental molybdenum in persons with cystic fibrosis: a case-control study in Colorado. Lipner EM; Crooks JL; French J; Strong M; Nick JA; Prevots DR J Expo Sci Environ Epidemiol; 2022 Mar; 32(2):289-294. PubMed ID: 34218259 [TBL] [Abstract][Full Text] [Related]
16. Epidemiological trends in nontuberculous mycobacterial infection among people with cystic fibrosis in Germany. Steindor M; Hafkemeyer S; Ruckes C; Stehling F; Naehrlich L; Ringshausen FC Int J Infect Dis; 2023 Apr; 129():32-39. PubMed ID: 36736578 [TBL] [Abstract][Full Text] [Related]
18. Helping map the taxonomical position of the Nontuberculous Mycobacteria (NTM) in cystic fibrosis. Moore JE; Millar BC Int J Mycobacteriol; 2022; 11(3):303-308. PubMed ID: 36260450 [TBL] [Abstract][Full Text] [Related]
19. Household proximity to water and nontuberculous mycobacteria in children with cystic fibrosis. Bouso JM; Burns JJ; Amin R; Livingston FR; Elidemir O Pediatr Pulmonol; 2017 Mar; 52(3):324-330. PubMed ID: 28135043 [TBL] [Abstract][Full Text] [Related]
20. Use of Statistical Process Control Methods for Early Detection of Healthcare Facility-Associated Nontuberculous Mycobacteria Outbreaks: A Single-Center Pilot Study. Baker AW; Maged A; Haridy S; Stout JE; Seidelman JL; Lewis SS; Anderson DJ Clin Infect Dis; 2023 Apr; 76(8):1459-1467. PubMed ID: 36444485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]